P/E
Net profit
P/B
Book value
Debts
Net debt
Yield
Growth potential
Revvity news
10.05.2023
PerkinElmer changed its name to Revvity. On May 16, the company will begin trading under the new ticker RVTY.
Source: 
ir.revvity.com
ir.revvity.com
04.05.2022
Net income of PerkinElmer under GAAP for the 3 months of 2022 was $176.962 million, down 2.3 times from $379.305 million in the previous year. Revenue declined 3.7% to $1.259 billion from $1.308 billion a year earlier.
Source: ir.perkinelmer.com
29.04.2022
The PerkinElmer Board of Directors announced a quarterly dividend of $0.07 per share. The last day to buy securities to receive the dividend is July 20, 2022. The annual dividend yield may reach 0.12%.
Source: ir.perkinelmer.com
02.02.2022
PerkinElmer's GAAP net income for 2021 was $932.157 million, up 28.1% from $727.887 million in the prior year. Revenue increased 33.9% to $5.067 billion from $3.783 billion a year earlier.
Source: ir.perkinelmer.com
General information
| Company name | Revvity |
|---|---|
| Tags | #s&p500 index |
| Sector | Health Care / Pharmaceuticals, Biotechnology & Life Sciences / Life Sciences Tools & Services / Life Sciences Tools & Services |
| Business address | 940 WINTER STREET WALTHAM MA 02451 781 663 5776 |
| Mailing address | 940 WINTER STREET WALTHAM MA 02451 |
| Website | ir.revvity.com |
| Information disclosure | www.sec.gov |
English (US) 